IN2014DN03197A - - Google Patents

Download PDF

Info

Publication number
IN2014DN03197A
IN2014DN03197A IN3197DEN2014A IN2014DN03197A IN 2014DN03197 A IN2014DN03197 A IN 2014DN03197A IN 3197DEN2014 A IN3197DEN2014 A IN 3197DEN2014A IN 2014DN03197 A IN2014DN03197 A IN 2014DN03197A
Authority
IN
India
Prior art keywords
formulations
methods
compositions
preparation
well
Prior art date
Application number
Other languages
English (en)
Inventor
Pradeep M Gupte
Lapaz Robert Louis De
Ramanathan Ravichandran
Original Assignee
Rockland Technimed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockland Technimed Ltd filed Critical Rockland Technimed Ltd
Publication of IN2014DN03197A publication Critical patent/IN2014DN03197A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
IN3197DEN2014 2011-09-22 2012-09-22 IN2014DN03197A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161537823P 2011-09-22 2011-09-22
PCT/US2012/036604 WO2013043236A1 (en) 2011-09-22 2012-05-04 Compositions and methods useful for realtime in situ physiological molecular imaging of oxygen metabolism
PCT/US2012/056775 WO2013044186A1 (en) 2011-09-22 2012-09-22 Compositions and methods for molecular imaging of oxygen metabolism

Publications (1)

Publication Number Publication Date
IN2014DN03197A true IN2014DN03197A (enExample) 2015-05-22

Family

ID=47914739

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3197DEN2014 IN2014DN03197A (enExample) 2011-09-22 2012-09-22

Country Status (5)

Country Link
US (1) US20140234224A1 (enExample)
EP (1) EP2758034A4 (enExample)
CN (1) CN103917222A (enExample)
IN (1) IN2014DN03197A (enExample)
WO (2) WO2013043236A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3871666A1 (en) 2014-03-05 2021-09-01 Evan C. Unger Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
WO2015188040A2 (en) * 2014-06-05 2015-12-10 The Trustees Of Columbia University In The City Of New York Composition for use in imaging
IL260206B2 (en) * 2015-12-21 2023-04-01 Nuvox Pharma Llc Preparations containing a nanoemulsion of fluorocarbons and methods for their preparation
US20190365665A1 (en) * 2017-01-24 2019-12-05 Nuvox Pharma Llc Iso-osmotic and near iso-osmotic oxygen therapeutic formulations and methods thereof
US20180279878A1 (en) * 2017-04-04 2018-10-04 Canon Medical Systems Corporation Mri system, mri apparatus, and mri method
WO2019010445A1 (en) * 2017-07-07 2019-01-10 The Regents Of The University Of Colorado, A Body Corporate COMPOSITIONS AND METHOD FOR THE TREATMENT OF PULMONARY HYPERTENSION
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993581A (en) * 1973-10-05 1976-11-23 The Green Cross Corporation Process for preparing stable oxygen transferable emulsion
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US5554125A (en) * 1987-07-08 1996-09-10 Reynolds; David L. Prefilled vial syringe
US4996041A (en) * 1988-08-19 1991-02-26 Toshiyuki Arai Method for introducing oxygen-17 into tissue for imaging in a magnetic resonance imaging system
DE4019062A1 (de) * 1989-08-30 1991-03-07 Kali Chemie Ag Stabilisierung von perfluorcarbonemulsionen und als emulsionsstabilisierende zusaetze verwendbare perfluorierte heterocyclische verbindungen
US20020150539A1 (en) * 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5047627A (en) * 1990-05-18 1991-09-10 Abbott Laboratories Configuration fiber-optic blood gas sensor bundle and method of making
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6537246B1 (en) * 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6596235B2 (en) * 1999-09-30 2003-07-22 Therox, Inc. Method for blood oxygenation
US7179449B2 (en) * 2001-01-30 2007-02-20 Barnes-Jewish Hospital Enhanced ultrasound detection with temperature-dependent contrast agents
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
US20080119703A1 (en) * 2006-10-04 2008-05-22 Mark Brister Analyte sensor
WO2006108047A2 (en) * 2005-04-05 2006-10-12 Biopure Corporation Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization
US7410634B2 (en) * 2005-10-17 2008-08-12 Rockland Technimed Ltd. Tissue metabolic stress monitoring
US9000048B2 (en) * 2006-11-28 2015-04-07 Wisconsin Alumni Research Foundation Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
CN101199548B (zh) * 2007-12-11 2011-04-13 西安力邦医药科技有限责任公司 一种全氟化碳乳剂及其制备方法
WO2010121082A2 (en) * 2009-04-15 2010-10-21 Oxygen Biotherapeutics, Inc. Emulsions of perfluorocarbons

Also Published As

Publication number Publication date
WO2013044186A1 (en) 2013-03-28
WO2013043236A1 (en) 2013-03-28
EP2758034A1 (en) 2014-07-30
US20140234224A1 (en) 2014-08-21
CN103917222A (zh) 2014-07-09
EP2758034A4 (en) 2015-09-16

Similar Documents

Publication Publication Date Title
MX2015000813A (es) Composiciones liposómicas de inhibidores de proteasoma basadas en epoxicetona.
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
GEP20207146B (en) New gadolinium chelate compounds for use in magnetic resonance imaging
CA2818187C (en) Bromodomain inhibitors and uses thereof
EA201370018A1 (ru) Составы рифаксимина и их применение
MX2013005545A (es) Compuestos heterociclicos como sodas de imagenologia de la patologia tau.
WO2013070881A8 (en) Method for elimination of space through tissue approximation
WO2012149412A3 (en) Anti-endoglin (cd105) antibodies, immunoconjugates, and uses thereof
GEP201706745B (en) Forms of rifaximin and usage thereof
TN2012000512A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
MX2013007967A (es) Uso del antagonista del receptor tipo toll para el tratamiento del cancer.
BR112014017169A2 (pt) máquina de bebidas com módulo removível
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
MX357227B (es) Nanoparticulas basadas en lipidos.
MX2010006787A (es) Análogos halogenados de agentes anti-fibroticos.
MX2012007896A (es) Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica.
EA201490363A1 (ru) Новые составы на основе (триметоксифениламино)пиримидинилов
UY31587A1 (es) Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica.
IN2015DN00085A (enExample)
MX2016003725A (es) Compuestos y su uso para la preparacion de agentes de formacion de imagen tau y formulaciones para la formacion de imagen tau.
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
UY31592A1 (es) Compuestos de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica
IN2015DN02109A (enExample)
CY1113338T1 (el) Νεα μεθοδος για συνθεση ιβαμπραδινης και αλατων προσθηκης αυτης
IN2012DN02698A (enExample)